Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3185) 3185
Book Review (410) 410
Publication (258) 258
Newsletter (50) 50
Conference Proceeding (21) 21
Book Chapter (6) 6
Magazine Article (4) 4
Dissertation (2) 2
Newspaper Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
levofloxacin (2776) 2776
index medicus (2658) 2658
humans (2306) 2306
male (1320) 1320
female (1165) 1165
pharmacology & pharmacy (1153) 1153
anti-bacterial agents - therapeutic use (1097) 1097
middle aged (954) 954
microbiology (871) 871
adult (831) 831
infectious diseases (796) 796
ofloxacin - therapeutic use (790) 790
aged (775) 775
microbial sensitivity tests (702) 702
ciprofloxacin (695) 695
fluoroquinolones (687) 687
antibiotics (635) 635
treatment outcome (525) 525
anti-bacterial agents - pharmacology (504) 504
animals (421) 421
anti-bacterial agents - administration & dosage (384) 384
anti-infective agents - therapeutic use (377) 377
drug therapy, combination (373) 373
moxifloxacin (373) 373
levofloxacin - therapeutic use (371) 371
ofloxacin - pharmacology (360) 360
infections (349) 349
drug resistance, bacterial (346) 346
aged, 80 and over (337) 337
infection (336) 336
pneumonia (319) 319
resistance (313) 313
health aspects (310) 310
adolescent (302) 302
pharmacokinetics (298) 298
analysis (287) 287
ofloxacin - administration & dosage (281) 281
drug therapy (266) 266
quinolones (262) 262
helicobacter infections - drug therapy (261) 261
anti-bacterial agents - adverse effects (260) 260
drug resistance (258) 258
helicobacter pylori (257) 257
therapy (257) 257
clarithromycin (249) 249
young adult (247) 247
risk factors (246) 246
fluoroquinolones - therapeutic use (243) 243
drug resistance in microorganisms (230) 230
prospective studies (229) 229
ofloxacin - adverse effects (223) 223
community-acquired pneumonia (220) 220
research (216) 216
community-acquired infections - drug therapy (213) 213
anti-bacterial agents - pharmacokinetics (210) 210
antimicrobial resistance (210) 210
anti-infective agents - pharmacology (209) 209
bacteria (209) 209
internal medicine (208) 208
care and treatment (206) 206
gastroenterology & hepatology (203) 203
ofloxacin (202) 202
streptococcus-pneumoniae (202) 202
susceptibility (202) 202
ofloxacin - pharmacokinetics (201) 201
amoxicillin (200) 200
antimicrobial agents (199) 199
retrospective studies (197) 197
fluoroquinolones - pharmacology (194) 194
immunology (185) 185
streptococcus pneumoniae - drug effects (183) 183
dosage and administration (182) 182
medicine & public health (182) 182
medicine, general & internal (182) 182
helicobacter pylori - drug effects (181) 181
management (179) 179
efficacy (174) 174
bacterial pneumonia (172) 172
gatifloxacin (167) 167
pharmacodynamics (157) 157
antibiotic-resistance (156) 156
abridged index medicus (155) 155
infectious disease (155) 155
time factors (155) 155
fluoroquinolone (154) 154
oncology (153) 153
administration, oral (151) 151
in-vitro (148) 148
dose-response relationship, drug (145) 145
prevalence (141) 141
drug administration schedule (140) 140
pneumonia, bacterial - drug therapy (139) 139
ciprofloxacin - therapeutic use (138) 138
patients (137) 137
ciprofloxacin - pharmacology (135) 135
drugs (131) 131
bacterial infections - drug therapy (129) 129
metronidazole (129) 129
eradication (128) 128
mice (127) 127
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3002) 3002
Spanish (55) 55
Japanese (44) 44
French (39) 39
Russian (37) 37
Chinese (29) 29
German (13) 13
Italian (11) 11
Korean (4) 4
Turkish (3) 3
Dutch (2) 2
Hungarian (2) 2
Polish (2) 2
Bulgarian (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
by Chey, William D and Leontiadis, Grigorios I and Howden, Colin W and Moss, Steven F
American Journal of Gastroenterology, ISSN 0002-9270, 02/2017, Volume 112, Issue 2, pp. 212 - 238
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may... 
CONTAINING QUADRUPLE THERAPY | CONTAINING TRIPLE-THERAPY | IMMUNE THROMBOCYTOPENIC PURPURA | GASTROESOPHAGEAL-REFLUX DISEASE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PROTON-PUMP INHIBITOR | IRON-DEFICIENCY ANEMIA | RANDOMIZED CONTROLLED-TRIAL | DOSE DUAL THERAPY | LEVOFLOXACIN-BASED THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Humans | Salvage Therapy | Anti-Infective Agents - therapeutic use | Clarithromycin - therapeutic use | Bismuth - therapeutic use | Proton Pump Inhibitors - therapeutic use | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Treatment Failure | Amoxicillin - therapeutic use | Levofloxacin - therapeutic use | Drug Therapy, Combination | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments
by Gisbert, J. P and Romano, M and Gravina, A. G and Solís‐Muñoz, P and Bermejo, F and Molina‐Infante, J and Castro‐Fernández, M and Ortuño, J and Lucendo, A. J and Herranz, M and Modolell, I and del Castillo, F and Gómez, J and Barrio, J and Velayos, B and Gómez, B and Domínguez, J. L and Miranda, A and Martorano, M and Algaba, A and Pabón, M and Angueira, T and Fernández‐Salazar, L and Federico, A and Marín, A. C and McNicholl, A. G
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 04/2015, Volume 41, Issue 8, pp. 768 - 775
BackgroundThe most commonly used second-line Helicobacter pylori eradication regimens are bismuth-containing quadruple therapy and levofloxacin-containing... 
CLARITHROMYCIN | SUBCITRATE | METAANALYSIS | EFFICACY | RESISTANCE | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | SEQUENTIAL THERAPY | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-PRACTICE | Bismuth - administration & dosage | Prospective Studies | Esomeprazole - administration & dosage | Humans | Middle Aged | Male | Urea - analysis | Bismuth - therapeutic use | Esomeprazole - therapeutic use | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Levofloxacin - therapeutic use | Adult | Female | Amoxicillin - administration & dosage | Drug Therapy, Combination | Levofloxacin - administration & dosage | Breath Tests | Proton Pump Inhibitors - therapeutic use | Antidiarrheals - therapeutic use | Amoxicillin - therapeutic use | Aged | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Helicobacter pylori | Levofloxacin | Urea | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015
by Zagari, Rocco Maurizio and Romano, Marco and Ojetti, Veronica and Stockbrugger, Reinhold and Gullini, Sergio and Annibale, Bruno and Farinati, Fabio and Ierardi, Enzo and Maconi, Giovanni and Rugge, Massimo and Calabrese, Carlo and Di Mario, Francesco and Luzza, Francesco and Pretolani, Stefano and Savio, Antonella and Gasbarrini, Giovanni and Caselli, Michele
Digestive and Liver Disease, ISSN 1590-8658, 2015, Volume 47, Issue 11, pp. 903 - 912
Abstract Knowledge on the role of Helicobacter pylori (HP) infection is continually evolving, and treatment is becoming more challenging due to increasing... 
Gastroenterology and Hepatology | Italy | Management | Helicobacter pylori | Guidelines | INTESTINAL METAPLASIA | IMMUNE THROMBOCYTOPENIC PURPURA | CLARITHROMYCIN RESISTANCE | PROTON PUMP INHIBITORS | IRON-DEFICIENCY ANEMIA | GASTRIC-CANCER PATIENTS | SERUM PEPSINOGEN STATUS | HIGH-RISK | TRIPLE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | STOOL ANTIGEN TEST | Barrett Esophagus - complications | Dyspepsia - complications | Breath Tests | Helicobacter Infections - complications | Clarithromycin - therapeutic use | Bismuth - therapeutic use | Proton Pump Inhibitors - therapeutic use | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Urea | Gastroesophageal Reflux - complications | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Stomach Neoplasms - prevention & control | Amoxicillin - therapeutic use | Antigens, Bacterial - analysis | Levofloxacin - therapeutic use | Disease Management | Feces | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Gastroesophageal reflux | Fluocinolone acetonide | Gastrointestinal diseases | Helicobacter infections | Drug resistance | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antibiotic therapy vs appendectomy for treatment of uncomplicated acute appendicitis: The APPAC randomized clinical trial
by Salminen, Paulina and Paajanen, Hannu and Rautio, Tero and Nordström, Pia and Aarnio, Markku and Rantanen, Tuomo and Tuominen, Risto and Hurme, Saija and Virtanen, Johanna and Mecklin, Jukka-Pekka and Sand, Juhani and Jartti, Airi and Rinta-Kiikka, Irina and Grönroos, Juha M
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 06/2015, Volume 313, Issue 23, pp. 2340 - 2348
IMPORTANCE An increasing amount of evidence supports the use of antibiotics instead of surgery for treating patients with uncomplicated acute appendicitis.... 
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | NEGATIVE APPENDECTOMIES | NONOPERATIVE MANAGEMENT | METAANALYSIS | ADULTS | OUTCOMES | 1ST-LINE THERAPY | SUSPECTED APPENDICITIS | PERFORATION | Length of Stay | Acute Disease | Appendectomy | Appendix - pathology | Follow-Up Studies | Humans | Male | Laparoscopy | Young Adult | Anti-Bacterial Agents - therapeutic use | Administration, Intravenous | Emergency Treatment | Metronidazole - therapeutic use | Treatment Failure | Adolescent | Intention to Treat Analysis | Appendicitis - surgery | Levofloxacin - therapeutic use | Adult | Female | Drug Therapy, Combination | beta-Lactams - therapeutic use | Postoperative Complications | Appendicitis - drug therapy | Care and treatment | Usage | Antibiotics | Appendicitis | Clinical trials | Comparative analysis | Tomography | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: A Taiwanese nationwide study
by Chou, Hsu-Wen and Wang, Jiun-Ling and Chang, Chia-Hsuin and Lai, Chao-Lun and Lai, Mei-Shu and Chan, K. Arnold
Clinical Infectious Diseases, ISSN 1058-4838, 02/2015, Volume 60, Issue 4, pp. 566 - 577
Background. Previous studies have demonstrated increased cardiovascular mortality related to azithromycin and levofloxacin. Risks associated with alternative... 
ventricular arrhythmia | cardiovascular death | azithromycin | levofloxacin | moxifloxacin | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | PROPENSITY SCORE | CARDIOVASCULAR EVENTS | MICROBIOLOGY | DEATH | QT INTERVAL PROLONGATION | IMMUNOLOGY | CLAIMS DATA | PNEUMONIAE INFECTION | ANTIBACTERIAL DRUGS | ASSOCIATION | Arrhythmias, Cardiac - epidemiology | Arrhythmias, Cardiac - chemically induced | Arrhythmias, Cardiac - mortality | Comorbidity | Ciprofloxacin - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Logistic Models | Male | Risk | Clarithromycin - therapeutic use | Fluoroquinolones - adverse effects | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | beta-Lactamase Inhibitors - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Azithromycin - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Taiwan | Cardiovascular Diseases - mortality | Levofloxacin - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Levofloxacin - adverse effects | Taiwanese | Treatment outcome | Arrhythmia | Mortality | Macrolide antibiotics | Risk factors | Quinolones | Analysis | Beta lactam antibiotics | Quinolone antibacterial agents | Dosage and administration | Drug therapy | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals
by Leung, Wai K and Wong, Irene O.L and Wong, Angel Y.S and Wong, Ian C.K and Cheung, Ka Shing and Yeung, Kar Fu and Chan, Esther W and Chen, Lijia and Graham, David Y
Gastroenterology, ISSN 0016-5085, 07/2018, Volume 155, Issue 1, pp. 67 - 75
Although eradication of infection reduces the risk of gastric cancer, few data are available on its effects in older subjects. We compared the age-specific... 
Stomach Cancer | Bacteria | Antibiotics | Chemoprevention | CLARITHROMYCIN | POPULATION | METAANALYSIS | THERAPY | PREVENTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | Humans | Middle Aged | Risk Factors | Helicobacter Infections - epidemiology | Male | Clarithromycin - therapeutic use | Bismuth - therapeutic use | Proton Pump Inhibitors - therapeutic use | Incidence | Protective Factors | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Hong Kong - epidemiology | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Levofloxacin - therapeutic use | Adult | Female | Registries | Stomach Neoplasms - epidemiology | Aged | Retrospective Studies | Drug Therapy, Combination | Prevention | Analysis | Resveratrol | Helicobacter infections | Stomach cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Clinical trial: Clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication
by Molina-Infante, J and Perez-Gallardo, B and Fernandez-Bermejo, M and Hernandez-Alonso, M and Vinagre, G and DueÑas, C and Mateos-Rodriguez, J.M and Gonzalez-Garcia, G and Abadia, E.G and Gisbert, J.P
Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, 05/2010, Volume 31, Issue 10, pp. 1077 - 1084
P>Background Helicobacter pylori eradication rates with standard triple therapy have declined to unacceptable levels. Aim To compare clarithromycin and... 
ESOMEPRAZOLE | METAANALYSIS | EFFICACY | PROTON PUMP INHIBITOR | ANTIBIOTIC-RESISTANCE | PHARMACOLOGY & PHARMACY | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | AMOXICILLIN | THERAPY REGIMEN | CHILDREN | Anti-Ulcer Agents - therapeutic use | Levofloxacin | Omeprazole - therapeutic use | Humans | Middle Aged | Ofloxacin - therapeutic use | Helicobacter pylori - drug effects | Male | Treatment Outcome | Clarithromycin - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Adolescent | Amoxicillin - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Drug Therapy, Combination | Omeprazole | Clinical trials | Clarithromycin | Amoxicillin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of helicobacter pylori
by Basu, P. Patrick and Rayapudi, Krishna and Pacana, Tommy and Shah, Niraj James and Krishnaswamy, Nithya and Flynn, Molly
American Journal of Gastroenterology, ISSN 0002-9270, 11/2011, Volume 106, Issue 11, pp. 1970 - 1975
OBJECTIVES: Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was... 
UNITED-STATES | HELIOBACTER-PYLORI | RISK-FACTORS | METAANALYSIS | MANAGEMENT | EFFICACY | REGIMEN | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ANTIMICROBIAL RESISTANCE | CONSENSUS REPORT | Levofloxacin | Recurrence | Prospective Studies | Humans | Middle Aged | Ofloxacin - therapeutic use | Helicobacter Infections - complications | Male | Thiazoles - administration & dosage | Thiazoles - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Helicobacter Infections - drug therapy | Ofloxacin - administration & dosage | Adult | Female | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Doxycycline - therapeutic use | Omeprazole - administration & dosage | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Anti-Ulcer Agents - administration & dosage | Amoxicillin - therapeutic use | Intention to Treat Analysis | Anti-Bacterial Agents - administration & dosage | Lansoprazole | Protons | Clarithromycin | Clinical trials | Gastritis | Infection | Omeprazole | Side effects | Antibiotics | peptic ulcers | Amoxicillin | Doxycycline | Endoscopy | Feces | Index Medicus | Stomach
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Delamanid kills dormant mycobacteria in vitro and in a Guinea pig model of tuberculosis
by Chen, Xiuhao and Hashizume, Hiroyuki and Tomishige, Tatsuo and Nakamura, Izuru and Matsuba, Miki and Fujiwara, Mamoru and Kitamoto, Ryuki and Hanaki, Erina and Ohba, Yoshio and Matsumoto, Makoto
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2017, Volume 61, Issue 6
Tuberculosis (TB) treatment is long and requires multiple drugs, likely due to various phenotypes of TB bacilli with variable drug susceptibilities. Drugs with... 
Dormant | Guinea pig | Mycobacterium tuberculosis | Delamanid | guinea pig | HYPOXIC RESPONSE | RIFAMPIN | MICROBIOLOGY | DRUG-TOLERANT | CHEMOTHERAPY | RESISTANT | dormant | BACTERICIDAL ACTIVITY | BOVIS BCG | POPULATION PHARMACOKINETICS | PULMONARY TUBERCULOSIS | delamanid | PHARMACOLOGY & PHARMACY | OPC-67683 | Lung - microbiology | Isoniazid - pharmacology | Tuberculosis - microbiology | Levofloxacin - pharmacology | Mycobacterium tuberculosis - drug effects | Mycobacterium tuberculosis - pathogenicity | Pyrazinamide - pharmacology | Nitroimidazoles - therapeutic use | Ethionamide - pharmacology | Tuberculosis - drug therapy | Levofloxacin - therapeutic use | Isoniazid - therapeutic use | Rifampin - therapeutic use | Drug Therapy, Combination | Oxazoles - therapeutic use | Antitubercular Agents - therapeutic use | Lung - pathology | Guinea Pigs | Nitroimidazoles - pharmacology | Ethionamide - therapeutic use | Antitubercular Agents - pharmacology | Pyrazinamide - therapeutic use | Animals | Oxazoles - pharmacology | Rifampin - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
by Julio Ramirez and Nathalie Dartois and Hassan Gandjini and Jean Li Yan and Joan Korth-Bradley and Paul C. McGovern
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2013, Volume 57, Issue 4, pp. 1756 - 1762
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
INFECTIONS | SINGLE | PHARMACOKINETICS | LEVOFLOXACIN | FLUID | INTENSIVE-CARE UNITS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SERUM | EXPOSURE-RESPONSE ANALYSES | NOSOCOMIAL PNEUMONIA | Imipenem - therapeutic use | Imipenem - administration & dosage | Cilastatin - administration & dosage | Cilastatin - adverse effects | Humans | Middle Aged | Minocycline - analogs & derivatives | Male | Anti-Bacterial Agents - therapeutic use | Minocycline - adverse effects | Pneumonia - drug therapy | Minocycline - therapeutic use | Adult | Female | Minocycline - administration & dosage | Aged | Anti-Bacterial Agents - adverse effects | Cilastatin - therapeutic use | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Imipenem - adverse effects | Index Medicus | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis
by Stellah G. Mpagama and Norah Ndusilo and Suzanne Stroup and Happiness Kumburu and Charles A. Peloquin and Jean Gratz and Eric R. Houpt and Gibson S. Kibiki and Scott K. Heysell
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 782 - 788
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MYCOBACTERIUM-TUBERCULOSIS | GATIFLOXACIN | SUSCEPTIBILITY TESTS | BACTERICIDAL ACTIVITY | LEVOFLOXACIN | POPULATION PHARMACOKINETICS | TREATMENT OUTCOMES | PULMONARY TUBERCULOSIS | RIFAMPIN | PYRAZINAMIDE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Amikacin - pharmacokinetics | Humans | Middle Aged | Kanamycin - pharmacokinetics | Levofloxacin - pharmacokinetics | Ofloxacin - therapeutic use | Male | Tuberculosis, Pulmonary - drug therapy | Fluoroquinolones - pharmacokinetics | Mycobacterium tuberculosis - drug effects | Microbial Sensitivity Tests | Tuberculosis, Pulmonary - blood | Tuberculosis, Multidrug-Resistant - microbiology | Amikacin - blood | Levofloxacin - therapeutic use | Adult | Female | Kanamycin - blood | Antitubercular Agents - therapeutic use | Ofloxacin - blood | Ethionamide - therapeutic use | Pyrazinamide - pharmacokinetics | Tanzania | Levofloxacin - blood | Fluoroquinolones - therapeutic use | Kanamycin - therapeutic use | Ofloxacin - pharmacokinetics | Pyrazinamide - blood | Pyrazinamide - therapeutic use | Cycloserine - therapeutic use | Antitubercular Agents - blood | Ethionamide - pharmacokinetics | Amikacin - therapeutic use | Cycloserine - blood | Fluoroquinolones - blood | Antitubercular Agents - pharmacokinetics | Cycloserine - pharmacokinetics | Ethionamide - blood | Adolescent | Tuberculosis, Multidrug-Resistant - blood | Mycobacterium tuberculosis - growth & development | Tuberculosis, Multidrug-Resistant - drug therapy | Index Medicus | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text A comparative study of sequential therapy and standard triple therapy for helicobacter pylori infection: A randomized multicenter trial
by Zhou, Liya and Zhang, Jianzhong and Chen, Minhu and Hou, Xiaohua and Li, Zhaoshen and Song, Zhiqiang and He, Lihua and Lin, Sanren
American Journal of Gastroenterology, ISSN 0002-9270, 2014, Volume 109, Issue 4, pp. 535 - 541
OBJECTIVES: Studies conducted in large populations of patients and providing full information on Helicobacter pylori (H. pylori) antibiotic resistance are... 
CONCOMITANT THERAPY | MANAGEMENT | METAANALYSIS | LEVOFLOXACIN | EFFICACY | OPEN-LABEL | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Tinidazole - pharmacology | Multivariate Analysis | Humans | Middle Aged | Drug Resistance, Bacterial | Esomeprazole - pharmacology | Helicobacter pylori - drug effects | Male | Tinidazole - therapeutic use | Esomeprazole - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | China | Helicobacter Infections - drug therapy | Adult | Anti-Ulcer Agents - pharmacology | Female | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Anti-Ulcer Agents - therapeutic use | Drug Administration Schedule | Breath Tests | Logistic Models | Treatment Outcome | Clarithromycin - therapeutic use | Amoxicillin - pharmacology | Adolescent | Amoxicillin - therapeutic use | Intention to Treat Analysis | Aged | Anti-Bacterial Agents - pharmacology | Helicobacter pylori - isolation & purification | Clarithromycin - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13.